Professional Documents
Culture Documents
Anticholinesterases: Kanav Bhanot Roll No. 5
Anticholinesterases: Kanav Bhanot Roll No. 5
Anticholinesterases: Kanav Bhanot Roll No. 5
KANAV BHANOT
ROLL NO. 5
CONTENTS
• GENERAL- Anticholinesterases
• MECHANISM OF ACTION
• THERAPEUTIC USES
• ADVERSE DRUG REACTIONS
• ORGANOPHOSPHOROUS POISONING
(TREATMENT)
ANTICHOLINESTERASES
TREATMENT-
Anti-cholinesterase agent (increase Ach)
1.Pyridostigmine 60-120 mg 3-4 times/day orally
[less frequent dosing compared to Neostigmine]
2. or Pyridostigmine 2 mg IM
3. Or Neostigmine 15 mg q 6hourly
V. POST-OPERATIVE DECURARIZATION
Neostigmine: 0.5-2mg IV Or Edrophonium